Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
第一作者:
Kristine A,Frerichs
第一单位:
Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.;Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
作者:
主题词
人类(Humans);多发性骨髓瘤(Multiple Myeloma);免疫, 体液(Immunity, Humoral);免疫球蛋白类, 静脉内(Immunoglobulins, Intravenous);抗体, 双特异性(Antibodies, Bispecific);B细胞成熟抗原(B-Cell Maturation Antigen);抗肿瘤药(Antineoplastic Agents);营养保健品(Dietary Supplements)
DOI
10.1182/bloodadvances.2023011658
PMID
38052042
发布时间
2024-01-15
- 浏览1

Blood advances
2024年8卷1期
194-206页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文